Analysis of Factors Influencing Early Neurological Deterioration after Emergency Interventional Thrombolysis in Patients with Acute Cerebral Infarction
ZHANG Feng, JI Liu, GE Chunyang, et al
Hefei Second People's Hospital, Anhui Hefei 230011, China
Abstract:Objective: To investigate the factors influencing early neurological deterioration (END) after emergency interventional thrombolysis in patients with acute cerebral infarction. Methods: A total of 105 patients with acute cerebral infarction who underwent emergency interventional thrombolysis in our hospital from March 2020 to March 2023 were enrolled in this study. According to whether END occurred within 24 hours after thrombolysis, the patients were divided into the END group (n=34) and the non-END group (n=71). Univariate analysis was used to analyze the factors related to END, and multivariate logistic regression analysis was used to analyze the independent risk factors for END. Results: Univariate analysis showed no significant differences between the END and non-END groups in terms of gender, age, BMI, smoking history, drinking history, hypertension history, diabetes history, coronary heart disease history, and distribution of the responsible large vessel (P>0.05). However, the degree of stenosis of the responsible large vessel was significantly different between the END and non-END groups (P<0.05). Univariate analysis of the quantitative data showed that the National Institutes of Health Stroke Scale (NIHSS) score, thrombolysis time, white blood cell count, neutrophil count, Lp-PLA2 level, and lipoprotein a level were significantly different between the END and non-END groups (P<0.05). However, there were no significant differences between the END and non-END groups in terms of time from onset to thrombolysis, D-dimer level, and Hcy level (P>0.05). Multivariate logistic regression analysis showed that the degree of stenosis of the responsible large vessel, NIHSS score on admission, thrombolysis time, white blood cell count, neutrophil count, Lp-PLA2, and lipoprotein a were independent risk factors for END. Conclusion: The incidence of END after emergency interventional thrombolysis in patients with acute cerebral infarction is high and is influenced by multiple factors. The degree of stenosis of the responsible large vessel, NIHSS score on admission, thrombolysis time, white blood cell count, neutrophil count, Lp-PLA2, and lipoprotein a are independent risk factors for END.
张峰, 季流, 葛春阳, 李海山. 急性脑梗死患者急诊介入溶栓治疗后早期神经功能恶化影响因素分析[J]. 河北医学, 2024, 30(4): 613-618.
ZHANG Feng, JI Liu, GE Chunyang, et al. Analysis of Factors Influencing Early Neurological Deterioration after Emergency Interventional Thrombolysis in Patients with Acute Cerebral Infarction. HeBei Med, 2024, 30(4): 613-618.
[1] Masson A,Boulouis G,Janot K,et al.Acute hydrocephalus and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage[J].Acta Neurochir,2022,164(9):2401-2408. [2] Liu F,Jin M,Zhang Z,et al.Platelet-to-neutrophil ratio is related to hemorrhagic transformation in patients with acute cerebral infarction[J].Neurologist,2022,27(5):230-234. [3] 孙瑜,魏爱宣,王利民,等.急性脑梗死静脉溶栓后早期神经功能恶化的影像学特征分析[J].中国实验诊断学,2023,27(5):568-571. [4] 刘雪云,方琪,吴小三,等.脑白质高信号与急性缺血性脑卒中静脉溶栓后早期神经功能恶化的相关性研究[J].中华神经医学杂志,2022,21(3):257-262. [5] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中.中国急性缺血性脑卒中诊治指南2010[J].中国全科医学,2011,14(35):4013-4017. [6] 谈颂,常思远,宋波,等.早期改良美国国立卫生研究院卒中量表评分对缺血性卒中诊治指南(2014)[J].中华神经科杂志,2015,48(4):246-257. [7] Shao YJ,Zhang Y,Wu RR,et al.Network pharmacology approach to investigate the multitarget mechanisms of Zhishi Rhubarb Soup on acute cerebral infarction[J].Pharm Biol,2022,60(1):1394-1406. [8] Bao H,Gao HR,Pan ML,et al.Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction[J].Technol Health Care,2021,29(1):85-90. [9] 穆永芳,郭永力,蒋召芹,等.阿替普酶治疗急性脑梗死患者的疗效、血清ET-1、TXA2水平及不良反应影响[J].湖南师范大学学报(医学版),2022,19(2):208-211. [10] 兰翠霞,王健,王江凤,等.血清Lp-PLA2、RDW-CV、NLR值变化与急性脑梗死患者早期神经功能恶化及预后的关系[J].中国现代医学杂志,2023,33(10):12-17. [11] 华键,周其达.急性脑梗死早期神经功能恶化与高密度脂蛋白胆固醇及脂蛋白(a)的关系[J].中华老年心脑血管病杂志,2018,20(4):405-407.